Faculty: James Underberg, MD, MS (Chair); Robert Giugliano, MD, SM; Marc Sabatine, MD, MPH
Program Overview:
In this symposium, lipid experts Dr. Robert Giugliano,
Dr. Marc Sabatine, and Dr. James Underberg will describe best practices
for internists in managing LDL-C cholesterol and reducing the risk for
major cardiovascular events with the addition of nonstatin therapy.
Educational Objectives:
Upon completion of his program, attendees should be able to:
Recognize that LDL-C remains a central focus of cardiovascular
risk reduction.
Discuss the basic principles of cholesterol management and the
role of statin therapy.
Indicate patient populations that may benefit from the addition of
nonstatin therapy for further LDL-C reduction and further ASCVD
risk reduction.
Explain clinical trial evidence for use of PCSK9 inhibitors
and ezetimibe.
Identify barriers to prescribing PCSK9 inhibitors and describe
strategies to overcome these barriers
Target Audience:
This educational activity is intended for internists.
Accreditation & Credit Designation:
Voxmedia LLC is accredited by the Accreditation Council for Continuing
Medical Education (ACCME) to provide continuing medical education
for physicians.
Voxmedia LLC designates this live activity for a maximum of 2.0 AMA
PRA Category 1 Credit(s)TM. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and
earn a certificate of completion as AANP accepts AMA PRA Category 1
CreditsTM through its reciprocity agreements.
The National Commission on Certification of Physician Assistants
accepts AMA PRA Category 1 Credits TM from organizations accredited by
the ACCME.
Educational Grant:
Voxmedia International gratefully acknowledges the educational donation
provided by Amgen.